Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Human Chorionic Gonadotropin

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,329,976Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    KRS Global Biotechnology Issues Voluntary Nationwide Recall of All Human and Animal Sterile Drug Products
    KRS Global Biotechnology Issues Voluntary Nationwide Recall of All Human and Animal Sterile Drug Products

    14 Sep 2019

    // FDA

    https://www.pharmacompass.com/pdf/news/KRS-Global-Biotechnology-Issues-Voluntary-Nationwide-Recall-of-All-Human-and-Animal-Sterile-Drug-Products-1568424609.pdf

    FDA
    14 Sep 2019
    Share Share
    Enforcement Report - Week of June 19, 2019
    Enforcement Report - Week of June 19, 2019

    19 Jun 2019

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-19-2019-1560925761.pdf

    FDA
    19 Jun 2019
    Share Share
    Enforcement Report - Week of December 26, 2018
    Enforcement Report - Week of December 26, 2018

    26 Dec 2018

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-december-26-2018-1545811500.pdf

    FDA
    26 Dec 2018
    Share Share
    Hybrid Pharma Receives FDA Warning Letter
    Hybrid Pharma Receives FDA Warning Letter

    12 Dec 2018

    // FDA

    https://www.pharmacompass.com/pdf/news/hybrid-pharma-receives-fda-warning-letter-1549703483.pdf

    FDA
    12 Dec 2018
    Share Share
    Inventive Infusion Solutions Receives FDA Form 483
    Inventive Infusion Solutions Receives FDA Form 483

    27 Sep 2018

    // FDA

    https://www.pharmacompass.com/pdf/news/inventive-infusion-solutions-receives-fda-form-483-1538036934.pdf

    FDA
    27 Sep 2018
    Share Share
    Enforcement Report - Week of September 5, 2018
    Enforcement Report - Week of September 5, 2018

    05 Sep 2018

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-september-5-2018-1536113909.pdf

    FDA
    05 Sep 2018
    Share Share